| 22nd Nov 2024 7:00 am |
RNS |
Notice of Results |
| 21st Nov 2024 11:06 am |
RNS |
NIHR and OLS Funding Package |
| 4th Nov 2024 1:29 pm |
RNS |
Scottish Health Technology Group publications |
| 21st Oct 2024 3:22 pm |
RNS |
Director Declaration |
| 15th Aug 2024 10:39 am |
RNS |
Director/PDMR Shareholding |
| 12th Aug 2024 7:00 am |
RNS |
First UK commercial sales of the CYP2C19-ID Kit |
| 6th Aug 2024 7:00 am |
RNS |
Directorate Change |
| 31st Jul 2024 7:00 am |
RNS |
NICE recommends CYP2C19-ID Kit in final guidance |
| 15th Jul 2024 7:00 am |
RNS |
Breakthrough Device Designation from the U.S. FDA |
| 27th Jun 2024 9:28 am |
RNS |
Short extension to NICE publication date |
| 25th Jun 2024 7:00 am |
RNS |
Holding(s) in Company |
| 24th Jun 2024 11:13 am |
RNS |
Holding(s) in Company |
| 24th Jun 2024 11:12 am |
RNS |
Holding(s) in Company |
| 24th Jun 2024 11:11 am |
RNS |
Holding(s) in Company |
| 17th Jun 2024 4:41 pm |
RNS |
Holding(s) in Company |
| 13th Jun 2024 3:22 pm |
RNS |
Holding(s) in Company |
| 11th Jun 2024 12:54 pm |
RNS |
Holding(s) in Company |
| 7th Jun 2024 11:00 am |
RNS |
Holding(s) in Company |
| 5th Jun 2024 3:45 pm |
RNS |
Holding(s) in Company |
| 5th Jun 2024 11:39 am |
RNS |
Holding(s) in Company |
| 31st May 2024 3:56 pm |
RNS |
Block listing returns |
| 31st May 2024 11:24 am |
RNS |
Result of General Meeting |
| 30th May 2024 7:00 am |
RNS |
Result of Open Offer and REX Offer |
| 24th May 2024 7:00 am |
RNS |
Initial orders of the Genedrive MT-RNR1 Products |
| 21st May 2024 11:00 am |
RNS |
Key CYP2C19-ID test performance milestone achieved |
| 15th May 2024 7:00 am |
RNS |
Amendment to Open Offer timetable |
| 14th May 2024 7:00 am |
RNS |
Publication of Circular and Notice of GM |
| 10th May 2024 7:00 am |
RNS |
Completion of placing |
| 9th May 2024 4:49 pm |
RNS |
Proposed REX Retail Offer |
| 9th May 2024 4:48 pm |
RNS |
Proposed Fundraise for a minimum of £6.0 million |
| 24th Apr 2024 3:36 pm |
RNS |
Clinical Trial Agreement |
| 3rd Apr 2024 5:00 pm |
RNS |
Application for Listing & Total Voting Rights |
| 3rd Apr 2024 7:00 am |
RNS |
NICE recommends the Genedrive CYP2C19-ID Kit |
| 28th Mar 2024 7:00 am |
RNS |
Half-year Report |
| 26th Mar 2024 7:00 am |
RNS |
Investor presentation |
| 19th Mar 2024 3:53 pm |
RNS |
Application for Listing & Total Voting Rights |
| 15th Mar 2024 12:30 pm |
RNS |
Receipt of R&D tax credit |
| 19th Feb 2024 7:00 am |
RNS |
NICE Early Value Assessment update |
| 6th Feb 2024 2:03 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Feb 2024 3:35 pm |
RNS |
Total Voting Rights |
